Connect with us

Business

Prescription For Growth: Pharma, Health Sectors Seek R&D Boost, Higher Spending From Budget 2026

Published

on

Prescription For Growth: Pharma, Health Sectors Seek R&D Boost, Higher Spending From Budget 2026


Last Updated:

Industry leaders say Budget 2026 is a crucial moment to shift from a volume-driven healthcare economy to one anchored in innovation, prevention and long-term resilience

Calling for higher public health spending, the corporate honchos & healthcare lobbies have asked for targeted tax incentives for research and manufacturing, regulatory reforms to support innovation and affordability. Representational image

Calling for higher public health spending, the corporate honchos & healthcare lobbies have asked for targeted tax incentives for research and manufacturing, regulatory reforms to support innovation and affordability. Representational image

India’s pharmaceutical and healthcare sectors have pitched for a strong policy push in the Union Budget to raise health spending, revive R&D incentives and reform regulations to strengthen global competitiveness.

Calling for higher public health spending, the corporate honchos & healthcare lobbies have asked for targeted tax incentives for research and manufacturing, regulatory reforms to support innovation and affordability.

Industry leaders told News18 that while India has emerged as a global supplier of affordable medicines and medical devices, mounting pressures from geopolitical uncertainty, tariff barriers, supply-chain disruptions and rising non-communicable diseases (NCDs) require sustained fiscal and policy support.

The coming Budget on Sunday, they argue, is a crucial moment to shift from a volume-driven healthcare economy to one anchored in innovation, prevention and long-term resilience.

At the core of the demands are calls to revive incentives for pharmaceutical research and development, address tax and GST anomalies affecting manufacturing, strengthen domestic MedTech production, and expand public healthcare financing in line with national health targets. Healthcare providers, meanwhile, are seeking reforms in insurance coverage, reimbursements and preventive care as disease patterns shift sharply towards chronic illnesses.

Pharma: R&D push, tax reforms and manufacturing competitiveness

Pharmaceutical companies have urged the government to reinforce India’s innovation ecosystem through globally competitive R&D incentives and a stable policy environment.

According to Sudarshan Jain, secretary general, Indian Pharmaceutical Alliance, the lobby of the domestic pharma companies, including Sun Pharma, Cipla, Glenmark and IPCA Labs, “The industry seeks globally competitive R&D incentives that align with India’s innovation ambitions, enhance the scientific ecosystem, and support the transition from a volume-driven model to an innovation-led pharmaceutical sector.”

The industry is seeking restoration of the weighted R&D tax deduction of up to 200% and a strengthened patent box regime with a competitive 5% tax rate to support innovation in complex generics, biosimilars, vaccines and novel drugs. Companies have also flagged the need to rationalise GST structures to correct inverted duty anomalies that strain manufacturing viability.

Satish Reddy, chairman of pharma giant Dr Reddy’s Laboratories, believes that as the industry undertakes a strategic shift from volume-led expansion to value-driven growth, “closer alignment between science, policy and industry will be critical to advancing innovation across the value chain”. He added that expectations from the budget centre on structured funding frameworks to deepen R&D and enable translation of advanced research into high-value therapies.

“With the sector poised to play a pivotal role in realising the vision of Viksit Bharat and its ambition of becoming a $500 billion industry by 2047, expectations from the Union Budget 2026 centre on the creation of a structured funding framework to deepen innovation and R&D across the country. This would enable the companies to translate advanced research into complex, high-value therapies while improving patient access,” he suggested.

The MedTech industry echoed similar concerns, particularly regarding taxation and domestic capability-building.

“For India to build a truly competitive MedTech manufacturing ecosystem, the sector needs a policy approach that reduces cost disabilities, nurtures local innovation and enables faster market access,” Himanshu Baid, managing director at medtech firm, Poly Medicure. He flagged the inverted GST duty structure, where finished devices attract lower tax rates than inputs, leading to working capital pressures.

Global technology players also emphasised the role of artificial intelligence and exports. Dev Tripathy, head of finance, Philips (Indian Subcontinent), said, “Delivering quality healthcare to the last mile is crucial for India, and this can only be achieved by leveraging AI.”

Tripathy explained that AI will enable “early diagnosis and consolidate data points, helping clinicians make accurate decisions and bridge the supply-demand gap”. “India has the talent to drive AI-led innovation, and incentives for AI innovation, job creation, and high-end service exports through global capability centres (GCCs) must be prioritised,” he said.

Health: NCD burden, insurance gaps and preventive care

On the healthcare delivery side, hospital leaders and diagnostics players highlighted the growing dominance of non-communicable diseases and the need to pivot from episodic treatment to prevention-led care.

Ameera Shah, promoter and executive chairperson at diagnostic lab chain Metropolis Healthcare, said that India stands at a defining moment in its healthcare transition. “With non-communicable diseases projected to account for nearly 75 per cent of morbidity and mortality by 2030 and the economic cost of NCDs estimated at USD 6 trillion over the next decade, the country must urgently pivot from episodic care to comprehensive, holistic care, which is prevention-led, viable and resilient healthcare systems—an essential pillar of the Viksit Bharat vision,” said Shah, president, NATHEALTH, an apex healthcare body serving as a credible and unified voice in improving access and quality of healthcare.

Hospitals have also flagged pressure points in insurance coverage and reimbursements. Dr Purshotam Lal, director-interventional cardiologist and chairman, Metro Group of Hospitals, expects the government to widen Ayushman Bharat–Pradhan Mantri Jan Arogya Yojna (PMJAY). He added that with rising diabetes, hypertension, cardiovascular disease and cancers — especially among younger populations — India needs an insurance model that prioritises preventive healthcare.

Moreover, operational sustainability remains another concern, according to Dr Sanjeev Gupta, medical director, Sri Balaji Action Medical Institute and Action Cancer Hospital, New Delhi, who pointed to delayed reimbursements under government schemes. He said that “timely settlement of dues and clearer pricing frameworks are essential to maintain quality healthcare delivery”, adding that periodic review of package rates was necessary to keep pace with advances such as robotic surgeries and new therapies.

“In an era of rapid innovation, including robotic-assisted surgeries and advanced therapeutics, several government schemes have limited coverage for such procedures, along with capping on certain critical drugs. Periodic review of package rates is therefore essential to keep policies aligned with evolving clinical practices,” said Dr Gupta.

Together, industry leaders argue that Budget 2026 must balance affordability with innovation, strengthen domestic manufacturing, and reorient healthcare delivery towards prevention and early diagnosis — a shift they say is essential to protect both public health and long-term economic growth.

News business Prescription For Growth: Pharma, Health Sectors Seek R&D Boost, Higher Spending From Budget 2026
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Petrol and diesel prices may rise if Middle East crisis persists, says RBI Governor Sanjay Malhotra – The Times of India

Published

on

Petrol and diesel prices may rise if Middle East crisis persists, says RBI Governor Sanjay Malhotra – The Times of India


Reserve Bank Governor Sanjay Malhotra has said the government may eventually have to raise petrol and diesel prices if the ongoing Middle East crisis continues for a prolonged period, PTI reported on Wednesday.Speaking at a conference in Switzerland on Tuesday, Malhotra said the disruption in oil and gas supplies due to the conflict and blockade of the Strait of Hormuz has begun impacting India, which remains heavily dependent on energy and fertiliser imports.Referring to the crisis, the RBI governor said if it continues for a longer duration, it is a “matter of time that the government will actually pass on some of these price increases”.The government has so far not increased retail petrol and diesel prices despite the conflict in West Asia that began on February 28.Malhotra also said the government has remained fiscally prudent and continues on the path of fiscal consolidation.The comments come amid rising pressure on India’s external sector due to elevated crude oil prices and a weakening rupee, which has slipped below the 95 mark against the US dollar.Prime Minister Narendra Modi had earlier called for measures such as reducing fuel consumption and lowering edible oil usage to help conserve foreign exchange reserves.As global crude oil prices surge amid the prolonged Middle East conflict and disruptions around the Strait of Hormuz, India has so far avoided major increases in petrol and diesel prices, choosing instead to absorb the pressure through state-run oil marketing companies (OMCs), tax adjustments and supply management measures.The Centre has repeatedly asserted that there is no fuel shortage in the country and no plan to introduce rationing of petrol, diesel or LPG despite disruptions in global energy shipments linked to the Iran conflict and the Strait of Hormuz crisis.“There is no need to panic. There are sufficient supplies. There is no rationing in place. It’s not going to happen,” Oil Secretary Neeraj Mittal said recently at the CII Annual Business Summit.Officials said India currently maintains around 60 days of fuel stocks and nearly 45 days of LPG inventories despite continuing volatility in global energy markets.

OMC losses mount as crude prices surge

The government’s decision to hold retail fuel prices steady despite rising international crude rates has increased pressure on state-run oil companies.According to official discussions reviewed during recent government briefings, OMCs are estimated to be losing between Rs 1,000 crore and Rs 1,200 crore every day because of elevated crude prices and unchanged pump rates.Under-recoveries are estimated to have approached nearly Rs 2 lakh crore during the first quarter of 2026.The current crisis intensified after shipping movement through the Strait of Hormuz — a key global oil transit route handling nearly one-fifth of global crude flows — came under severe disruption during the Iran conflict.Brent crude prices surged above $110 per barrel during the latest phase of the crisis, sharply increasing import costs for major oil-consuming countries like India. India imports nearly 90 per cent of its crude oil requirements, making the economy highly vulnerable to global energy price shocks.

Govt focuses on supply stability, inflation control

The Centre has simultaneously attempted to prevent inflationary shocks and avoid panic in domestic fuel markets.Officials said India has increased procurement from alternate suppliers and secured additional energy cargoes to maintain uninterrupted supplies.“We have procured from other sources. We have procured from other countries. We have increased procurement from existing countries and that has kept us going in terms of supply management in the short run,” Mittal said.The government has also absorbed part of the global price shock through excise duty adjustments on petrol and diesel. Officials estimate the revenue impact of fuel-related tax reductions at nearly Rs 1.6 lakh crore.Prime Minister Narendra Modi on Sunday (May 10) urged citizens to conserve fuel, reduce unnecessary imports and avoid wasteful consumption as rising oil prices increase pressure on India’s import bill and foreign exchange reserves. The Prime Minister also encouraged greater use of public transport, carpooling, electric vehicles and work-from-home arrangements wherever possible. The government has described these as precautionary steps rather than emergency restrictions.

Pressure likely to continue

Fuel prices remain among the most politically sensitive economic issues in India because increases in petrol and diesel rates directly affect transport costs, food prices and household budgets.While the Centre has so far avoided large retail fuel price increases, analysts say prolonged suppression of prices could further strain OMC finances if crude prices remain elevated for a longer period.



Source link

Continue Reading

Business

Companies start getting tariff refunds after Supreme Court decision

Published

on

Companies start getting tariff refunds after Supreme Court decision


Containers at the Port of Oakland in Oakland, California, US, on Thursday, March 26, 2026.

David Paul Morris | Bloomberg | Getty Images

Months after the Supreme Court ruled some tariffs were unconstitutional, the first round of tariff refunds has begun flowing in.

Oshkosh Corporation CFO Matt Field confirmed to CNBC that the company has started receiving tariff refunds as of Tuesday.

“Following acceptance of our initial filing, we have begun receiving payments on our tariff refund claims, representing an initial portion of our total claims submitted,” Field said.

The company has not yet verified its total refund amount, Field added.

Basic Fun, the company behind Care Bears and Tonka trucks, also told CNBC it began receiving tariff refunds on Tuesday.

CEO Jay Foreman said the refunds so far have only represented 5% of the company’s total claim on its early invoices.

“We will utilize the refund dollars to help support our 2026 cash flow and invest in our team. This is the toughest time of the year for toy companies,” Foreman said in a statement. “We’ll also be announcing to our staff that we will be increasing salaries to help offset cost of living increase, announcing promotions and larger merit increases. We are reinvesting the funds in our business and people.”

Logistics companies UPS, FedEx and DHL have previously said that they will file for tariff refunds on behalf of their customers, requiring no further action from them. The first phase of tariff refunds only covers requests for entries that CBP finalized within the past 80 days, though that process could take months to reach customers.

The U.S. Customs and Border Protection said in a court filing that it anticipated paying refunds of $35.46 billion on 8.3 million shipments, as of Monday morning.

In February, the Supreme Court invalidated President Donald Trump‘s tariffs imposed under the International Emergency Economic Powers Act of 1977. In the months that followed, companies began filing for tariff refunds in a portal, called the Consolidated Administration and Processing of Entries.

In a radio interview with WABC on Tuesday morning, Trump called the tariff refund situation “crazy.”

“In theory, you have to pay the tariffs back. We’ll fight that,” Trump said. “We were taking in fortunes from people that hate us, countries and companies that hate us.”

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source link

Continue Reading

Business

FinMin discusses budget preparations, macroeconomic outlook with IMF mission – SUCH TV

Published

on

FinMin discusses budget preparations, macroeconomic outlook with IMF mission – SUCH TV



Finance Minister Muhammad Aurangzeb on Wednesday briefed the visiting International Monetary Fund (IMF) mission on the country’s macroeconomic outlook, fiscal strategy, reform priorities, and the government’s ongoing efforts to ensure sustainable economic stability and long-term growth.

The meeting with the visiting IMF mission, led by Mission Chief Iva Petrova, focused on Pakistan’s macroeconomic stabilisation efforts, preparations for the upcoming federal budget, and the broader reform agenda aimed at strengthening fiscal and external sustainability while fostering sustainable economic growth.

During the meeting, both sides exchanged views on maintaining reform momentum, preserving macroeconomic stability, and advancing structural reforms to promote investment, productivity, and export-led growth within a balanced and forward-looking policy framework.

The finance minister appreciated the IMF’s continued engagement and constructive dialogue with the government of Pakistan.

He particularly acknowledged the productive discussions initiated during the Spring Meetings held in Washington earlier this year.

Senator Aurangzeb shared encouraging developments regarding Pakistan’s external sector, highlighting positive trends in remittances and export performance.

He noted that recent data indicated improvement in exports on both a month-on-month and year-on-year basis, reflecting growing resilience in the economy and a gradual strengthening of macroeconomic fundamentals.

The minister emphasised that while economic stabilisation efforts had produced encouraging results, the government remained fully mindful of the structural challenges confronting the economy, particularly external liabilities and the need to accelerate sustainable, export-led growth.

He reiterated the government’s commitment to deepening reforms aimed at strengthening macroeconomic stability without compromising long-term growth prospects.

In this regard, he underscored the importance of moving Pakistan away from recurring boom-and-bust cycles through structural reforms, productivity enhancement, deregulation, and improved export competitiveness.

The minister further stated that the government’s reform agenda had been carefully calibrated in consultation with international experts and economists.

He emphasised that the ongoing policy measures were not driven by short-term considerations, but formed part of a broader and technically grounded economic transformation strategy endorsed at the highest level.

The IMF mission acknowledged the positive progress made by Pakistan in maintaining macroeconomic stability despite a challenging global and regional environment.

The Mission appreciated the government’s continued commitment to prudent economic management and reform implementation.

It emphasised the importance of sustaining reform momentum, maintaining fiscal discipline, and advancing structural reforms to support durable and inclusive economic growth.

Discussions during the meeting also focused on the broader macroeconomic framework, the government’s reform agenda, and priorities for the upcoming budget.

The mission reaffirmed its commitment to continued engagement and constructive cooperation with Pakistan in support of the country’s economic reform programme and long-term economic resilience.



Source link

Continue Reading

Trending